TY - JOUR
KW - Adult
KW - Buprenorphine, Naloxone Drug Combination/therapeutic use
KW - Drug Users
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Opiate Substitution Treatment
KW - Substance-Related Disorders/rehabilitation
KW - Buprenorphine experiences
KW - Diversion
KW - polysubstance use
AU - R. Walker
AU - T. K. Logan
AU - Q. T. Chipley
AU - J. Miller
A1 - 
AB - BACKGROUND: With a rise in overdoses and medical emergencies related to opioids, buprenorphine-naloxone (bup-nx) is seen as a preferred treatment for opioid dependence. However, the research examining experiences with bup-nx among polysubstance users who may or may not be opioid dependent has been limited. OBJECTIVES: The purpose of the study was to examine use, characteristics of users, and experiences of bup-nx use among polysubstance users entering drug-free recovery programs. METHODS: This study examined secondary data on 896 opioid or opiate user individuals (53.4% male) collected by drug-free, self-help-based residential recovery centers during intake. RESULTS: One-quarter of users said bup-nx helped them with their substance use while 75% of bup-nx users reported that bup-nx either had no effect or a negative effect on their drug problems. Of the very few (4%-7%) obtaining bup-nx solely through a prescription, over 90% reported relief from withdrawal. However, over 80% of those who obtained bup-nx through illicit means reported using bup-nx until their preferred drug could be obtained and used it for its euphoriant effect. Three groups of opioid users were created including one group with no bup-nx use, one with lifetime but not recent bup-nx use, and one with recent (past 6 month) use. There were differences in substance use patterns and characteristics of bup-nx experiences between the different groups. CONCLUSIONS: Results suggest that the views of bup-nx by individuals in drug-free recovery centers are varied, with many seeing bup-nx as not unlike other opioids while others report bup-nx as self-medication.
AD - a Department of Behavioral Science and the Center on Drug and Alcohol Research, College of Medicine , University of Kentucky , Lexington , KY, USA.; a Department of Behavioral Science and the Center on Drug and Alcohol Research, College of Medicine , University of Kentucky , Lexington , KY, USA.; b Health Sciences Center Campus, School of Medicine, Medical Student Affairs , University of Louisville , Louisville , KY, USA.; a Department of Behavioral Science and the Center on Drug and Alcohol Research, College of Medicine , University of Kentucky , Lexington , KY, USA.
BT - The American Journal of Drug and Alcohol Abuse
C5 - Opioids & Substance Use; Healthcare Disparities
CP - 6
CY - England
DO - 10.1080/00952990.2018.1461876
IS - 6
JF - The American Journal of Drug and Alcohol Abuse
LA - eng
M1 - Journal Article
N2 - BACKGROUND: With a rise in overdoses and medical emergencies related to opioids, buprenorphine-naloxone (bup-nx) is seen as a preferred treatment for opioid dependence. However, the research examining experiences with bup-nx among polysubstance users who may or may not be opioid dependent has been limited. OBJECTIVES: The purpose of the study was to examine use, characteristics of users, and experiences of bup-nx use among polysubstance users entering drug-free recovery programs. METHODS: This study examined secondary data on 896 opioid or opiate user individuals (53.4% male) collected by drug-free, self-help-based residential recovery centers during intake. RESULTS: One-quarter of users said bup-nx helped them with their substance use while 75% of bup-nx users reported that bup-nx either had no effect or a negative effect on their drug problems. Of the very few (4%-7%) obtaining bup-nx solely through a prescription, over 90% reported relief from withdrawal. However, over 80% of those who obtained bup-nx through illicit means reported using bup-nx until their preferred drug could be obtained and used it for its euphoriant effect. Three groups of opioid users were created including one group with no bup-nx use, one with lifetime but not recent bup-nx use, and one with recent (past 6 month) use. There were differences in substance use patterns and characteristics of bup-nx experiences between the different groups. CONCLUSIONS: Results suggest that the views of bup-nx by individuals in drug-free recovery centers are varied, with many seeing bup-nx as not unlike other opioids while others report bup-nx as self-medication.
PP - England
PY - 2018
SN - 1097-9891; 0095-2990
SP - 595
EP - 603
EP - 
T1 - Characteristics and experiences of buprenorphine-naloxone use among polysubstance users
T2 - The American Journal of Drug and Alcohol Abuse
TI - Characteristics and experiences of buprenorphine-naloxone use among polysubstance users
U1 - Opioids & Substance Use; Healthcare Disparities
U2 - 29693427
U3 - 10.1080/00952990.2018.1461876
VL - 44
VO - 1097-9891; 0095-2990
Y1 - 2018
ER -